Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Looky Here,

You hit the nail on the head. I remember years ago owning USAT and NMKT. I managed to sell at a small loss on both. The entire time the prices plummeted everyone claimed conspiracy. The reality was the companies were terribly run and mis-managed. The last time I checked that wasn't a crime, they were just idiots. I suggest everyone sit tight before you walk head first off the plank. Did Pohl and company have our best interest in mind? You bet they didn't.

The problem with this situation is the tale of two halfs. For those of us who have been around long enough we've been witness to the first act, and it wasn't pretty. The biggest challenge, to me personally, is showing restraint while the 2nd act is being written. We've all waited patiently for company to move on their promise to diversify and put our capital to work. Think about what's occured in RG's short tenure versus the pevious 3 years. I understand, unfortunately, what hasn't occurred which is an improving S/P the only metric that really matters to us. I knew this was going to be a long term play when RG joked in the video about wishing he had the divy money back. Why, because he knows the 1st act written must have been a comedy because no one in their right mind would have done what previous mgmt did. The challenge for us now it to afford him time to make moves, all be it small, with the capital he has left. All IMO.

Share
New Message
Please login to post a reply